Health care quality

Health Care Quality May Put Employers at Risk: White Paper and Webinar Hosted by The Leapfrog Group and ERISA Experts Address a New Regulatory Challenge

Retrieved on: 
Thursday, July 13, 2023
Legal, Mental Health, Labor, Public Policy, Government, Healthcare Reform, Professional Services, Health, Pharmaceutical, General Health, Omnibus spending bill, Zoom, Care Act 2014, United States Department of Labor, CAA, Consolidated Appropriations Act, 2018, Employee Retirement Income Security Act of 1974, Pharmacy, Affordable Care Act, Health care quality, Health policy, Health insurance, ERISA

One rarely discussed requirement: Employers and other purchasers must now take responsibility for health benefits that are cost-effective, high quality, and meet mental health parity and pharmacy benefit requirements.

Key Points: 
  • One rarely discussed requirement: Employers and other purchasers must now take responsibility for health benefits that are cost-effective, high quality, and meet mental health parity and pharmacy benefit requirements.
  • Register for the webinar for early access to the new white paper, “The CAA and Health Care Quality,” coauthored by experts in ERISA law, fiduciaries and health policy.
  • The experts will dissect new requirements and provide guidance on how ERISA employers can comply to drive quality health care.
  • This webinar and white paper offers suggestions on one of the most overlooked but critical aspects of the new law: addressing quality of health care.

Hospital Mergers Trigger Antitrust Concerns in Sham Peer Reviews of Physicians, according to Journal of American Physicians and Surgeons

Retrieved on: 
Monday, June 19, 2023
Peer review, Physician, AAPS, Immunity, Health care quality, Association of American Physicians and Surgeons, American Medical Association, Congress, Hospital, Journal, Patient, HCQIA, AMA, Health, Nursing, Surgeon

“In the quest to create larger and more robust monopolies, some hospitals are using sham peer review to remove the last remnants of independent physicians practicing in hospitals,” writes Lawrence Huntoon , M.D., Ph.D., in the summer issue of the Journal of American Physicians and Surgeons.

Key Points: 
  • “In the quest to create larger and more robust monopolies, some hospitals are using sham peer review to remove the last remnants of independent physicians practicing in hospitals,” writes Lawrence Huntoon , M.D., Ph.D., in the summer issue of the Journal of American Physicians and Surgeons.
  • “The creation of large hospital monopolies, with hospitals influencing the care provided by its employed physicians, has led to antitrust concerns,” Dr. Huntoon states.
  • HCQIA created virtually absolute immunity for hospitals conducting sham peer review; that is, reviews conducted in bad faith for reasons unrelated to improving patient care.
  • While acknowledging that “a sanction by a peer review body can be a devastating blow to a physician, emotionally, financially, and professionally,” the American Medical Association (AMA) was skeptical about the existence or significance of sham peer review.

ACGME Releases CLER National Report of Findings 2022: COVID-19 Pandemic and Its Impact on the Clinical Learning Environment

Retrieved on: 
Wednesday, December 14, 2022
Well, Graduate medical education, Physician, Health care quality, Health, MACP, Accreditation, Hospital, Professional, Learning, GME, Education, Accreditation Council, ACGME, Patient safety, Population health, Clinical, Accreditation Council for Graduate Medical Education, COVID-19, MPH, Medicine, Link aggregation, MD

Chicago, IL, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The Accreditation Council for Graduate Medical Education (ACGME) is pleased to present the CLER National Report of Findings 2022: The COVID-19 Pandemic and Its Impact on the Clinical Learning Environment .

Key Points: 
  • Chicago, IL, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The Accreditation Council for Graduate Medical Education (ACGME) is pleased to present the CLER National Report of Findings 2022: The COVID-19 Pandemic and Its Impact on the Clinical Learning Environment .
  • The ACGME’s Clinical Learning Environment Review (CLER) Program provides leaders of hospitals, medical centers, and other clinical settings with formative feedback through site visits that explore six Focus Areas: Patient Safety; Health Care Quality; Supervision; Teaming; Well-Being; and Professionalism.
  • The report identifies opportunities to optimize both patient care and GME in addressing challenges that are likely to persist as clinical sites recover from the COVID-19 pandemic’s acute phases.
  • “The pandemic has had monumental impact on our health care environment and has presented an unprecedented opportunity for learning.

Physicians Can Fight Back against Sham Peer Review, according to Journal of American Physicians and Surgeons (AAPS)

Retrieved on: 
Tuesday, December 6, 2022
Association of American Physicians and Surgeons, Physician, Health care quality, Health, American College, HCQIA, Peer review, Immunity, Journal, Ethics, Professional, AAPS, National Association Medical Staff Services, ACHE, Patient, Pharmaceutical industry, Medicine, Surgeon

Litigation is a lengthy and expensive process with an uncertain outcome, he writes.

Key Points: 
  • Litigation is a lengthy and expensive process with an uncertain outcome, he writes.
  • Physicians who participate in sham peer review have no immunity against having to explain their actions to a medical board, and if found culpable, being sanctioned accordingly.
  • Administrators who participate in sham peer review and who belong to the American College of Healthcare Executives (ACHE) can be reported to ACHE to assess whether they have violated the organization’s code of ethics.
  • The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS) , a national organization representing physicians in all specialties since 1943.

Cogitativo Announces Strategic Hires to Strengthen its Growth in Precision Health Initiatives for the US Government

Retrieved on: 
Wednesday, September 7, 2022
Health care quality, Patient, CEO, Medical Center, VHA, Associate, Solution, Kaiser Permanente, Veterans Health Administration, Blue Shield, Manchester VA Medical Center, Health, Minneapolis Veterans Affairs Health Care System, Data science, Veterans' affairs, Hospital, Leadership, Pharmacy, Integrated Services Digital Network, Mind–body, Senior advisor, Blue Shield of California, Efficiency, CMO, Management

BERKELEY, Calif. , Sept. 7, 2022 /PRNewswire/ -- Cogitativo announced today the promotion of Terry Gilliland, M.D., to Chief Medical Officer (CMO) and hiring of Joe Battle as Senior Advisor to the CEO.

Key Points: 
  • As CMO, Dr. Gilliland will set direction for the organization's clinical initiatives, oversee quality, and provide leadership in collaboration with federal health systems, including the Veterans Health Administration (VHA).
  • "Dr. Gilliland is an experienced leader in healthcare innovation," said Gary Velasquez, CEO of Cogitativo.
  • "His expertise will play a critical part in rolling out our precision health and wellness strategies."
  • Dr. Gilliland is the former Chief Science Officer at Cogitativo and Executive Vice President of Health Care Quality and Affordability at Blue Shield of California.

The American Board of Quality Assurance and Utilization Review Physicians Celebrates 45 Years of Excellence in Health Care Quality and Patient Safety

Retrieved on: 
Monday, August 29, 2022
Fellows, Patient safety, Health care quality, Hotel manager, Accreditation Council for Continuing Medical Education, Quality assurance, Accreditation Council, Management, Accreditation, American Board of Commissioners for Foreign Missions, Solution, Continuing medical education, Network, Education, NEW, Association, Movement, Professional, Board of directors, Conference, Element, CME, Certification, Knowledge, ACCME, Approximation error, Commendation, Hospital, Medical device, Medicine

NEW PORT RICHIE, Fla., Aug. 29, 2022 /PRNewswire-PRWeb/ -- The American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) is proud to announce that October 2022 marks the 45th Anniversary of ABQAURP's dedication to Health Care Quality and Management and Patient Safety.

Key Points: 
  • NEW PORT RICHIE, Fla., Aug. 29, 2022 /PRNewswire-PRWeb/ -- The American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) is proud to announce that October 2022 marks the 45th Anniversary of ABQAURP's dedication to Health Care Quality and Management and Patient Safety.
  • Later recognizing the need to address the whole care continuum, the Health Care Quality and Management (HCQM) Certification evolved to incorporate more elements of quality management and patient safety initiatives.
  • ABQAURP's commitment to these issues will shape the future as certification and education continue to promote health care quality and patient safety throughout the health care field.
  • Celebrating 45 years of excellence in Health Care Quality Management and Patient Safety, ABQAURP is a premier professional association providing Health Care Quality and Management (HCQM) certification, ACCME-accredited continuing medical education, and membership to health care professionals worldwide.

Cantourage kick-starts business in growing UK medical cannabis market with award of pharmaceutical licences and CQC registration to prescribe to patients

Retrieved on: 
Wednesday, April 13, 2022
EMA, Department of Health and Social Care, CEO, Care Quality Commission, Prescription, Social work, Plant, Narcotic, Medication, Compliance, Medicines and Healthcare products Regulatory Agency, GMP, Abuse, Department, European Medicines Agency, Patient, DHSC, Terpene, Home, Growth, Pharmacy, Health care quality, WDA, MHRA, Cannabidiol, Health care, CQC, Home Office, Drug, Medicine, Pharmaceutical industry, EU

LONDON and BERLIN, April 13, 2022 /PRNewswire/ -- European medical cannabis company Cantourage has received two British government licences that authorise the company to import medical cannabis into the UK. The company has also received the required regulatory registration to prescribe medical cannabis products to clients via a new facility, Cantourage Clinic.

Key Points: 
  • The company has also received the required regulatory registration to prescribe medical cannabis products to clientsvia a new facility, Cantourage Clinic.
  • In addition, Cantourage UK received regulatory registration for " Cantourage Clinic ", a private tele-healthcare clinic specialised in medical cannabis.
  • These three licences position Cantourage in the UK medicinal cannabis market, which is forecast to reach approximately US$1.3 billion with almost 400,000 patients by 2024[1].
  • Cantourage UK imports medical cannabis products from Germany into the UK and Channel Islands, supplying a broad range of products to patients throughout the country.

Cantourage kick-starts business in growing UK medical cannabis market with award of pharmaceutical licences and CQC registration to prescribe to patients

Retrieved on: 
Wednesday, April 13, 2022
Department of Health and Social Care, CEO, Care Quality Commission, Prescription, Social work, Plant, Narcotic, Medication, Compliance, Medicines and Healthcare products Regulatory Agency, GMP, Abuse, Department, Patient, DHSC, Terpene, Health care quality, Home, Growth, Pharmacy, WDA, MHRA, Cannabidiol, Health care, CQC, Home Office, Drug, Medicine, Pharmaceutical industry

LONDON and BERLIN, April 13, 2022 /PRNewswire/ -- European medical cannabis company Cantourage has received two British government licences that authorise the company to import medical cannabis into the UK. The company has also received the required regulatory registration to prescribe medical cannabis products to clients via a new facility, Cantourage Clinic.

Key Points: 
  • The company has also received the required regulatory registration to prescribe medical cannabis products to clientsvia a new facility, Cantourage Clinic.
  • In addition, Cantourage UK received regulatory registration for " Cantourage Clinic ", a private tele-healthcare clinic specialised in medical cannabis.
  • These three licences position Cantourage in the UK medicinal cannabis market, which is forecast to reach approximately US$1.3 billion with almost 400,000 patients by 2024[1].
  • Cantourage UK imports medical cannabis products from Germany into the UK and Channel Islands, supplying a broad range of products to patients throughout the country.

Latest Report on Global Challenge of Falls by Essence SmartCare and the Aging2.0 Collective Reveals Negative Impact of Covid-19 Pandemic and Highlights the Need for Better Mitigation through Technological Solutions

Retrieved on: 
Tuesday, March 1, 2022
Risk, Health care quality, Movement, Population, Death, COVID-19, City, Collective, Health, Trauma, General manager, Intelligence, Founder, Ageing, Exercise, Falls, Technology, Frailty, Solution, Research, CEO, Health insurance, Risk management, Essence

HERZLIYA, Israel, March 1, 2022 /PRNewswire/ -- Essence SmartCare, a leader in remote care and telehealth solutions and services, and the Aging2.0 Collective, the corporate innovation arm of Aging2.0, the global innovation platform for aging, today released findings of a new report charting the impact of falls as the biggest accident-based killer of people over 65, and the increased risk from falling suffered by seniors since the start of the Covid-19 pandemic.

Key Points: 
  • The Global Falls Innovation Report shows that falls represent the second leading cause of accidental or unintentional injury deaths worldwide.
  • The report estimates that, worldwide, a total of 646,000 individuals die from falls every year, representing 73 deaths every hour.
  • Drawn from dozens of peer-reviewed studies on elderly care, the research further analyzes how the ongoing pandemic has exacerbated fall-related challenges.
  • The report warns that, if preventive and proactive measures are not taken in the immediate future, "catastrophic consequences" will ensue.

Latest Report on Global Challenge of Falls by Essence SmartCare and the Aging2.0 Collective Reveals Negative Impact of Covid-19 Pandemic and Highlights the Need for Better Mitigation through Technological Solutions

Retrieved on: 
Tuesday, March 1, 2022
People, Risk, Health care quality, Movement, Population, Death, COVID-19, City, Collective, Health, Trauma, General manager, Intelligence, Founder, Ageing, Exercise, Falls, Technology, Frailty, Solution, CEO, Incidents, Health insurance, Risk management, Research, Essence

HERZLIYA, Israel, March 1, 2022 /PRNewswire/ -- Essence SmartCare, a leader in remote care and telehealth solutions and services, and the Aging2.0 Collective, the corporate innovation arm of Aging2.0, the global innovation platform for aging, today released findings of a new report charting the impact of falls as the biggest accident-based killer of people over 65, and the increased risk from falling suffered by seniors since the start of the Covid-19 pandemic.

Key Points: 
  • The Global Falls Innovation Report shows that falls represent the second leading cause of accidental or unintentional injury deaths worldwide.
  • The report estimates that, worldwide, a total of 646,000 individuals die from falls every year, representing 73 deaths every hour.
  • Drawn from dozens of peer-reviewed studies on elderly care, the research further analyzes how the ongoing pandemic has exacerbated fall-related challenges.
  • The report warns that, if preventive and proactive measures are not taken in the immediate future, "catastrophic consequences" will ensue.